105 related articles for article (PubMed ID: 11820608)
21. The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma.
Ranjbari N; Rahim F
Med Hypotheses; 2013 Mar; 80(3):311-4. PubMed ID: 23313072
[TBL] [Abstract][Full Text] [Related]
22. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
23. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid.
Muro-Cacho CA; Holt T; Klotch D; Mora L; Livingston S; Futran N
Otolaryngol Head Neck Surg; 1999 Feb; 120(2):200-7. PubMed ID: 9949353
[TBL] [Abstract][Full Text] [Related]
25. An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas.
Wang Y; Zhu JF; Liu YY; Han GP
Diagn Pathol; 2013 Jan; 8():8. PubMed ID: 23327593
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland.
Goto A; Sakamoto A; Machinami R
Pathol Res Pract; 2001; 197(4):217-22. PubMed ID: 11358005
[TBL] [Abstract][Full Text] [Related]
27. Low level of cyclin D1 protein expression in thyroid microcarcinomas from an autopsy series.
Kovacs GL; Stelkovics E; Krenacs L; Gonda G; Goth M; Kovacs L; Gorombey Z; Hubina E; Szabolcs I
Endocrine; 2005 Feb; 26(1):41-4. PubMed ID: 15805584
[TBL] [Abstract][Full Text] [Related]
28. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
[TBL] [Abstract][Full Text] [Related]
29. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
30. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 expression in benign and differentiated malignant tumors of the thyroid gland: diagnostic and biologic implications.
Seybt TP; Ramalingam P; Huang J; Looney SW; Reid MD
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):124-30. PubMed ID: 22553812
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Temmim L; Ebraheem AK; Baker H; Sinowatz F
Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications.
Pickett CA; Agoff SN; Widman TJ; Bronner MP
Thyroid; 2005 May; 15(5):461-73. PubMed ID: 15929668
[TBL] [Abstract][Full Text] [Related]
34. Cyclin E expression in papillary thyroid carcinoma: relation to staging.
Brzeziński J; Migodziński A; Gosek A; Tazbir J; Dedecjus M
Int J Cancer; 2004 Mar; 109(1):102-5. PubMed ID: 14735474
[TBL] [Abstract][Full Text] [Related]
35. Studies on expression of p14ARF and MDM2 in human thyroid neoplasms.
Qi XW; Wu HR; Yin Y; Xia SH; Feng JJ; Pu Y; Jin LF
Panminerva Med; 2015 Mar; 57(1):43-7. PubMed ID: 25386766
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast.
Loh SF; Cooper C; Selinger CI; Barnes EH; Chan C; Carmalt H; West R; Gluch L; Beith JM; Caldon CE; O'Toole S
J Clin Pathol; 2015 Mar; 68(3):187-91. PubMed ID: 25501285
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
38. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature.
Putti TC; Bhuiya TA
Pathology; 2000 Nov; 32(4):286-9. PubMed ID: 11186427
[TBL] [Abstract][Full Text] [Related]
39. Correlation of cytoplasmic beta-catenin and cyclin D1 overexpression during thyroid carcinogenesis around Semipalatinsk nuclear test site.
Meirmanov S; Nakashima M; Kondo H; Matsufuji R; Takamura N; Ishigaki K; Ito M; Prouglo Y; Yamashita S; Sekine I
Thyroid; 2003 Jun; 13(6):537-45. PubMed ID: 12930597
[TBL] [Abstract][Full Text] [Related]
40. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
